Alector Inc reports results for the quarter ended March 31 - Earnings Summary

• Alector Inc ALEC.OQ reported a quarterly adjusted loss of 41 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -38 cents. The mean expectation of six analysts for the quarter was for a loss of 48 cents per share. Wall Street expected results to range from -54 cents to -41 cents per share.

• Revenue fell 76.9% to $3.67 million from a year ago; analysts expected $4.38 million.

• Alector Inc's reported EPS for the quarter was a loss of 41 cents​.

• The company reported a quarterly loss of $40.47 million.

• Alector Inc shares had fallen by 17.1% this quarter and lost 46.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Alector Inc is $4.50

This summary was machine generated from LSEG data May 9 at 12:17 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)